BRANDI A MENDONCA

Allopathic & Osteopathic Physicians|Family Medicine MCMINNVILLE, OR NPI 1306941869

General Payments — all program years on this page

$3,324.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 196
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $467.43 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $467.4321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $907.2759
2019 $1,034.5669
2020 $128.267
2021 $225.1313
2022 $228.4813
2023 $333.1614
2024 $467.4321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086141051 Bayer Healthcare Pharmaceuticals Inc. $22.71 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086251160 Bayer Healthcare Pharmaceuticals Inc. $14.63 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096577935 Novo Nordisk Inc $22.38 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096655202 Novo Nordisk Inc $23.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096896281 Novo Nordisk Inc $14.55 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096930582 Novo Nordisk Inc $19.71 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104553050 AstraZeneca Pharmaceuticals LP $24.94 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104663513 AstraZeneca Pharmaceuticals LP $31.72 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104754136 AstraZeneca Pharmaceuticals LP $16.20 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105021572 ABBVIE INC. $26.56 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105487545 AstraZeneca Pharmaceuticals LP $21.88 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115823975 GlaxoSmithKline, LLC. $20.33 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115826409 GlaxoSmithKline, LLC. $16.64 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117958364 Boehringer Ingelheim Pharmaceuticals, Inc. $23.66 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118941949 Otsuka America Pharmaceutical, Inc. $21.86 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124978935 Abbott Laboratories $19.07 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136019250 Lilly USA, LLC $21.72 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136073591 Lilly USA, LLC $29.51 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136085074 Lilly USA, LLC $21.16 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139195166 Amneal Pharmaceuticals LLC $29.92 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143277339 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.29 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.